Riskpilot← Back to searchSign inGet full accessLäkarkonsult Doc RalBe AB
ABIn liquidationOrg 5591786685Lilla Bommen 3 BGeneral medical practice activities · NACE 8621Est. 20180 employees
Revenue 2025
SEK 9K
-93% vs 2024
EBITDA margin
-633.3%
-119% vs 2024
Equity ratio
80.5%
Financial strength
Net profit 2025
SEK -55K
-1163% vs 2024
| Revenue | SEK 9K | -93% |
| EBITDA | SEK -57K | -119% |
| Net profit | SEK -55K | -1163% |
| Total assets | SEK 128K | -75% |
| Equity | SEK 103K | -78% |
| Employees | 0 | — |
Legal name
Läkarkonsult Doc RalBe AB
Org number
5591786685
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
6 november 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
utfärdandet av medicinsk intyg (tex invaliditetsintyg), medicinsk rådgivning, medicinsk sakkunnig yttrande, föreläsningar, medicinsk utbildning, jourverksamhet, leasing och handel av medicinska produkter, medicinska behandlingar med akupunktur, chiroterapie mm, skapande och handel med medicinsk literatur, konsulttjänster inom sjukvård och därtill hörande verksamhet.
Address
Lilla Bommen 3 B
Email
monica.lassarev@moorelassarev.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 217 | 106 | 206 | 123 | 9 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 133 | 41 | 94 | −26 | −57 |
| Depreciation & amort. | −8 | −8 | −8 | −17 | −0 |
| EBIT | 125 | 32 | 86 | −43 | −57 |
| Net financials | — | 0 | 5 | 39 | 2 |
| Profit before tax | 125 | 32 | 91 | −4 | −55 |
| Tax | −26 | −5 | −19 | — | −0 |
| Net profit | 99 | 27 | 72 | −4 | −55 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 467 | 433 | 517 | 503 | 128 |
| Equity | 378 | 405 | 477 | 473 | 103 |
| Long-term debt | 0 | — | — | — | 0 |
| Short-term debt | 89 | 28 | 40 | 30 | 25 |
| Total debt | 89 | 28 | 40 | 30 | 25 |
EBITDA margin
-633.3%
This company
15.8%
Market median
-4108% vs market
20212025
Equity ratio
80.5%
This company
38.2%
Market median
+111% vs market
20212025
Return on equity
-53.4%
This company
18.4%
Market median
-390% vs market
20212025
Net profit margin
-611.1%
This company
8.1%
Market median
-7644% vs market
20212025
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20212025
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MC Liquidator | Liquidator | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Läkarkonsult Doc RalBe AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Monica C Lassarev Gustafsson | Liquidator | 0 companies |
| Maria Beutinger | Deputy Board Member | 0 companies |
| Ralf Dieter Beutinger | Board of Directors | 0 companies |